Literature DB >> 31001762

The role of intestinal microbiota in the pathogenesis of colorectal carcinoma.

Jozef Kuzma1, Dittmar Chmelař1,2, Michal Hájek3,4, Alexandra Lochmanová1,5, Ivan Čižnár1,6, Miroslav Rozložník1, Miloslav Klugar7.   

Abstract

The symbiotic relationship between intestinal microbiota and the host is a major mechanism of prevention against the development of chronic and metabolic diseases. The intestinal microbiota provides several physiological functions of the organism from the creation of a natural functional barrier with a subsequent immunostimulatory activity up to affecting the energy metabolism of the host. Disruption of physiological intestinal microbiota is reported as one of the major etiological factors of initiation and progression of colorectal carcinoma (CRC). Chronic low-grade inflammation is associated with the development of CRC, through the production of inflammatory cytokines and reactive oxygen species. CRC occurs in association with high-protein and high-fat diets in combination with low-fiber intake. The problem of intestinal dysbiosis and oncological diseases is a multidisciplinary problem and it is necessary to focus on several fields of medicine such as public health, clinical pharmacology, and internal medicine. The aim of this review is describing the role of gut dysbiosis in pathogenesis of colorectal carcinoma.

Entities:  

Year:  2019        PMID: 31001762     DOI: 10.1007/s12223-019-00706-2

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  53 in total

Review 1.  Gut microbiota in health and disease.

Authors:  Inna Sekirov; Shannon L Russell; L Caetano M Antunes; B Brett Finlay
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

2.  Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats.

Authors:  B S Reddy; T Narisawa; P Wright; D Vukusich; J H Weisburger; E L Wynder
Journal:  Cancer Res       Date:  1975-02       Impact factor: 12.701

Review 3.  The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity.

Authors:  Ningwen Tai; F Susan Wong; Li Wen
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

4.  Colorectal carcinogenesis in germ-free and conventionally reared rats: different intestinal environments affect the systemic immunity.

Authors:  Luca Vannucci; Renata Stepankova; Hana Kozakova; Anna Fiserova; Pavel Rossmann; Helena Tlaskalova-Hogenova
Journal:  Int J Oncol       Date:  2008-03       Impact factor: 5.650

Review 5.  Mismatch Repair and Colon Cancer: Mechanisms and Therapies Explored.

Authors:  Stephen K H Li; Alberto Martin
Journal:  Trends Mol Med       Date:  2016-03-09       Impact factor: 11.951

6.  Genetic alterations in colorectal cancer.

Authors:  Tannaz Armaghany; Jon D Wilson; Quyen Chu; Glenn Mills
Journal:  Gastrointest Cancer Res       Date:  2012-01

7.  Structure, function and diversity of the healthy human microbiome.

Authors: 
Journal:  Nature       Date:  2012-06-13       Impact factor: 49.962

8.  Towards the human colorectal cancer microbiome.

Authors:  Julian R Marchesi; Bas E Dutilh; Neil Hall; Wilbert H M Peters; Rian Roelofs; Annemarie Boleij; Harold Tjalsma
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

Review 9.  Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Carcinogenesis.

Authors:  Shosuke Kawanishi; Shiho Ohnishi; Ning Ma; Yusuke Hiraku; Mariko Murata
Journal:  Int J Mol Sci       Date:  2017-08-19       Impact factor: 5.923

10.  Human gut microbiota community structures in urban and rural populations in Russia.

Authors:  Alexander V Tyakht; Elena S Kostryukova; Anna S Popenko; Maxim S Belenikin; Alexander V Pavlenko; Andrey K Larin; Irina Y Karpova; Oksana V Selezneva; Tatyana A Semashko; Elena A Ospanova; Vladislav V Babenko; Igor V Maev; Sergey V Cheremushkin; Yuriy A Kucheryavyy; Petr L Shcherbakov; Vladimir B Grinevich; Oleg I Efimov; Evgenii I Sas; Rustam A Abdulkhakov; Sayar R Abdulkhakov; Elena A Lyalyukova; Maria A Livzan; Valentin V Vlassov; Renad Z Sagdeev; Vladislav V Tsukanov; Marina F Osipenko; Irina V Kozlova; Alexander V Tkachev; Valery I Sergienko; Dmitry G Alexeev; Vadim M Govorun
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  5 in total

1.  Consumption of Yoghurt and Other Dairy Products and Risk of Colorectal Cancer in Iran: The IROPICAN Study.

Authors:  Giulia Collatuzzo; Monireh Sadat Seyyedsalehi; Abbas Rezaeianzadeh; Maryam Marzban; Hamideh Rashidian; Maryam Hadji; Farin Kamangar; Arash Etemadi; Eero Pukkala; Kazem Zendehdel; Paolo Boffetta
Journal:  Nutrients       Date:  2022-06-16       Impact factor: 6.706

Review 2.  The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development.

Authors:  Flavia Genua; Vedhika Raghunathan; Mazda Jenab; William M Gallagher; David J Hughes
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

3.  An Integrative Approach to Characterize the Early Phases of Dimethylhydrazine-Induced Colorectal Carcinogenesis in the Rat.

Authors:  Rita Silva-Reis; Catarina Castro-Ribeiro; Mariana Gonçalves; Tiago Ferreira; Maria João Pires; Carlos E Iglesias-Aguirre; Adrián Cortés-Martín; María V Selma; Juan Carlos Espín; Elisabete Nascimento-Gonçalves; Alexandra Moreira-Pais; Maria J Neuparth; Francisco Peixoto; Eduardo Rosa; Adelina Gama; Rita Ferreira; Paula A Oliveira; Ana I Faustino-Rocha
Journal:  Biomedicines       Date:  2022-02-09

4.  Intestinal Permeability and Depression in Patients with Inflammatory Bowel Disease.

Authors:  Miorita Melina Iordache; Cristina Tocia; Mariana Aschie; Andrei Dumitru; Mihaela Manea; Georgeta Camelia Cozaru; Lucian Petcu; Sabina E Vlad; Eugen Dumitru; Anca Chisoi
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

Review 5.  Effects of Lipopolysaccharide-Binding Protein (LBP) Single Nucleotide Polymorphism (SNP) in Infections, Inflammatory Diseases, Metabolic Disorders and Cancers.

Authors:  Leilei Meng; Zichen Song; Anding Liu; Uta Dahmen; Xiao Yang; Haoshu Fang
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.